THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
D000925:Anticoagulants; D003327:Coronary Disease; D003850:Deoxyribonuclease I; D004791:Enzyme Inhibitors; D005342:Fibrinolysis; D006493:Heparin; D006801:Humans; D011655:Pulmonary Embolism; D011749:Pyrogens; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D015912:Thrombolytic Therapy; D013927:Thrombosis; D014116:Toxicology
D000925:Anticoagulants; D004791:Enzyme Inhibitors; D011749:Pyrogens; D006493:Heparin; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase
ANTICOAGULANTS; CORONARY DISEASE; ENZYME INHIBITORS; FIBRINOLYSIS; HEPARIN; PULMONARY EMBOLISM; PYROGENS; STREPTODORNASE AND STREPTOKINASE; THROMBOSIS; TOXICOLOGIC REPORT